Aridis Pharmaceuticals Receives Orphan Drug Designation From the European Medicines Agency for AR-501 - BioSpace

Aridis Pharmaceuticals Receives Orphan Drug Designation From the European Medicines Agency for AR-501  BioSpace

Published: Jul 19, 2019. SAN JOSE, Calif., July 19, 2019 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) announced today that the European ...



Comments

Popular posts from this blog

Глушители. Приборы бесшумной стрельбы